Endpoints NewsOriginal article
AbCellera, Silence and InduPro all raise significant funding
Phase 2positivePositive
AI Analysis
Summary
AbCellera announced a $200M share offering following positive Phase 2 data in a hot flashes trial. Silence and InduPro also raised significant funding.
Clinical Trial Data
Phase
2
Primary Endpoint
Met
Outcome Details
hit the bar in Phase 2 hot flashes trial
Importance:7/10
Sentiment:
0.70
fundingPhase 2 positivehot flashesofferingCanadian biotech
Read the original article
Published by Endpoints News on August 12, 2026 3:25 PM